St. Louis-based medical technology startup Pierian has been acquired in a deal that creates a new company focused on advancing the use of precision medicine in health care.
PierianDx is a Missouri-based biotechnology company that offers solutions such as clinical genome sequencing and genomics interpretation for the healthcare sector.